CSL tipped for ‘modest’ vaccine earnings as overseas peers soar
SYDNEY: The global rollout of COVID-19 vaccines has failed to ignite CSL shares despite boosting
SYDNEY: The global rollout of COVID-19 vaccines has failed to ignite CSL shares despite boosting